Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-associated fatty liver
disease (MAFLD), is one of the most common causes of liver diseases worldwide. NAFLD is …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. NAFLD stages range from simple steatosis (NAFL) to non-alcoholic …

High fat diet-induced changes in gut microbiota have been linked to intestinal permeability
and metabolic endotoxemia, which is related to metabolic disorders. However, the influence …

During aging, body adiposity increases with changes in the metabolism of lipids and their
metabolite levels. Considering lipid metabolism, excess adiposity with increased lipotoxicity …

Metabolic inflammation in adipose tissue and the liver is frequently observed as a result of
diet-induced obesity in human and rodent studies. Although the adipose tissue and the liver …

Objective—Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the degradation
of the low-density lipoprotein receptor thereby elevating plasma low-density lipoprotein …

Abstract C57BL/6J-related mouse strains are widely used animal models for diet-induced
obesity (DIO). Multiple vendors breed C57BL/6J-related substrains which may introduce …

Metastasis requires cellular changes related to cell‐to‐cell and cell‐to‐matrix adhesion,
immune surveillance, activation of growth and survival signalling pathways, and epigenetic …

Introduction There are inconsistent findings regarding the effect of lipid-lowering agents on
nonalcoholic fatty liver disease (NAFLD). Proprotein Convertase Subtilisin/Kexin type 9 …

The cluster of differentiation 36 (CD36) is a scavenger receptor present on various types of
cells and has multiple biological functions that may be important in inflammation and in the …